You are here: Home

SURVMARK-2 will produce high impact cancer survival, incidence and mortality comparisons as part of the International Cancer Benchmarking Partnership (ICBP). The ICBP is a unique and innovative collaboration that brings together clinicians, policy-makers, researchers, and cancer data experts. It aims to measure international differences in cancer survival, and crucially, to identify factors that might be driving these differences.

The SURVMARK-2 project was launched in July 2016 and is set to be completed in early 2020.


Call for expertise transfer fellowship applications will soon be launched
Kick-off meeting of the executive group held in London on 27/28 March 2017. View photo
SURVMARK-2 call for data launched in July 2016 – 20 jurisdictions from 6 countries participating